title: Use of apolipoprotein parameters and endpoints in drug development and approval processes.
authors.affiliation: Lipid and Lipoprotein Laboratory, Oklahoma Medical Research Foundation, Oklahoma City, USA.
authors.forename: P
authors.initials: P
authors.lastname: Alaupovic
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001053:Apolipoproteins / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D003324:Coronary Artery Disease / Q000097:blood* / Q000188:drug therapy / Q000209:etiology; D017277:Drug Approval; D015507:Drugs, Investigational; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
chemical_list: D001053:Apolipoproteins; D015415:Biomarkers; D015507:Drugs, Investigational